Clusters and Networks as the Foundations of Innovation Dynamics in the Biopharmaceutical Industry

In order to explain why innovation activities are increasingly structuring through networking and agglomeration dynamics, numerous empirical and theoretical works in various disciplines (economics, geography, sociology, management) have stressed the crucial role of spatial proximity. Following this conviction, the idea has emerged that quot;clustersquot; has become the key competitive tools within a context of sustained innovation dynamics and rapid globalization, notably in high-tech industries. However, despite its wide spread among academics and practitioners, this conviction still lacks solid theoretical and empirical foundations. Drawing from the case of biopharmaceuticals, this paper aims at showing that if clusters are one of the keys of the processes underlying innovative activities and the diffusion of innovations, they are far from constituting a sufficient condition or even more necessarily the appropriate organizational and spatial form of these processes, particularly in a context of globalization and growing uncertainties